Kailera Therapeutics (KLRA) Stock Price & Financial Analysis
Kailera Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Kailera Therapeutics
What is the current stock price for KLRA?
As of the latest trading session, KLRA stock trades at $19.62. The 52-week range is $20.87–$28.23, with a day range of $19.01–$20.38.
What is the P/E ratio for KLRA?
The P/E ratio (Price-to-Earnings) for KLRA is shown in the Key Statistics section. This valuation metric helps compare Kailera Therapeutics, Inc. to industry peers.
Does KLRA pay dividends?
Kailera Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for KLRA?
Analyst ratings and recommendations for KLRA are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of KLRA?
Kailera Therapeutics's market capitalization is $373,721.76, classifying it as a micro-cap company. Kailera Therapeutics operates in the Healthcare sector within the Biotechnology industry.